Effects of specific α-1A/1D blocker on lower urinary tract symptoms due to double-J stent: A prospectively randomized study

Urological Research

Volumn 37, Issue 3, 2009, Pages 147-152

  Wang, Chung Jing ^a   Huang, Shi Wei ^a   Chang, Chien Hsing ^a  

^a St Martin De Porres Hospital   (Taiwan)

Author keywords

1A 1D blocker; Double J stent

Indexed keywords

BUPRENORPHINE; PLACEBO; TAMSULOSIN;

ADULT; AGED; ANOREXIA; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GENERAL CONDITION; HEART PALPITATION; HUMAN; HYPOTENSION; INTERNATIONAL PROSTATE SYMPTOM SCORE; JOB PERFORMANCE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SEXUAL FUNCTION; STRUCTURED QUESTIONNAIRE; SYNCOPE; URETER STENT; URETER STONE; URETEROLITHOTOMY; URETEROSCOPY; VOMITING;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; QUESTIONNAIRES; STENTS; SULFONAMIDES; URETERAL CALCULI;

EID: 67650035127     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00240-009-0182-8     Document Type: Article

References (24)

1. PD Zimskind TR Fetter JL Wilkerson 1967 Clinical use of long-term indwelling silicone rubber ureteral splints inserted cystoscopically J Urol 97 840 844
2. BH Chew BE Knudsen JD Denstedt 2004 The use of stents in contemporary urology Curr Opin Urol 14 111 115 10.1097/00042307-200403000-00011
3. RB Dyer MY Chen RJ Zagoria JD Regan CG Hood PK Kavanagh 2002 Complications of ureteral stent placement Radiographics 22 1005 1022
4. N Lawrentschuk JM Russell 2004 Ureteric stenting 25 years on: routine or risky? ANZ J Surg 74 243 247 10.1111/j.1445-2197.2004.02947.x
5. HB Joshi N Newns A Stainthorpe RP MacDonagh FX Keeley Jr 2003 Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure J Urol 169 1060 1064 10.1097/01.ju.0000049198.53424.1d
6. C Deliveliotis M Chrisofos E Gougousis A Papatsoris A Dellis IM Varkarkis 2006 Is there a role for alpha1-blockers in treating double-J stent-related symptoms? Urology 67 35 39 10.1016/j.urology.2005.07.038
7. S Richter A Ringel M Shalev 2000 The indwelling ureteric stent: a "friendly" procedure with unfriendly high morbidity BJU Int 85 408 411 10.1046/j.1464-410x.2000.00478.x
8. A Paz GE Amiel N Pick B Moskovitz O Nativ I Potasman 2005 Febrile complications following insertion of 100 double-J ureteral stents J Endourol 19 147 150 10.1089/end.2005.19.147
9. JD Denstedt G Reid M Sofer 2000 Advances in ureteral stent technology World J Urol 18 237 242 10.1007/PL00007074
10. DT Beiko BE Knudsen JD Denstedt 2003 Advances in ureteral stent design J Endourol 17 195 199 10.1089/089277903765444294 (Pubitemid 36666246)
11. JE Lingeman GM Preminger Y Berger J Denstedt L Goldstone J Segura 2003 Use of a temporary ureteral drainage stent after uncomplicated ureteroscopy: results from a phase II clinical trial Urology 169 1682 1688 10.1097/01.ju.0000055600.18515.a1
12. K Kawabe A Ueno Y Takimoto Y Aso H Kato 1990 Use of an alpha 1-blocker, YM617, in the treatment of benign prostatic hypertrophy J Urol 144 908 912
13. M Shibasaki K Sudoh O Inagaki W Uchida K Honda 1992 Effect of the optical isomers of YM-12617 on increased intra-urethral pressure induced by phenylephrine in anaesthetized dogs J Auton Pharmacol 12 4 263 268 10.1111/j.1474-8673.1992.tb00340.x
14. H Lepor R Tang E Shapito 1993 The alpha-adrenoceptor subtype mediating the tension of human prostatic smooth muscle Prostate 22 301 307 10.1002/pros.2990220404 (Pubitemid 23176271)
15. HB Joshi A Stainthorpe RP MacDonagh FX Keeley Jr AG Timoney 2001 Indwelling ureteral stents: valuation of quality of life to aid outcome analysis J Endourol 15 151 154 10.1089/089277901750134421 (Pubitemid 32290834)
16. HB Joshi A Stainthorpe RP MacDonagh FX Keeley Jr AG Timoney 2003 Indwelling ureteral stents: evaluation of symptoms, quality of life and utility J Urol 169 1065 1069 10.1097/01.ju.0000048980.33855.90
17. B Kupeli L Irkilata S Gurocak L Tunç M Kiraç Ü Karaoǧlan 2004 Does tamsulosin enhance lower ureteral stone clearance with or without shock wave lithotripsy? Urology 64 1111 1115 10.1016/j.urology.2004.07.020
18. F Porpiglia G Ghignone C Fiori D Fontana R Scarpa 2004 Nifedipine versus tamsulosin for the management of lower ureteral stones J Urol 172 568 571 10.1097/01.ju.0000132390.61756.ff
19. K Davenport AG Timoney FX Keeley Jr 2007 Effect of smooth muscle relaxant drugs on proximal human ureteric activity in vivo: a pilot study Urol Res 35 207 213 10.1007/s00240-007-0100-x
20. C Hampel R Gillitzer S Pahernik SW Melchior JW Thüroff 2005 Drug therapy of female urinary incontinence Urologe 44 244 255 10.1007/s00120-005- 0769-9
21. S Serels M Stein 1998 Prospective study comparing hyoscyamine, doxazosin, and combination therapy for the treatment of urgency and frequency in women Neurourol Urodyn 17 31 36 10.1002/(SICI)1520-6777(1998)17:1<31::AID- NAU6>3.0.CO;2-E
22. K Bregg RA Riehle Jr 1989 Morbidity associated with indwelling internal ureteral stents after shock wave lithotripsy J Urol 141 510 512 (Pubitemid 19089137)
23. JV Candela GC Bellman 1997 Ureteral stents: impact of diameter and composition on patient symptoms J Endourol 11 45 47 (Pubitemid 27132669)
24. A Rane A Saleemi D Cahill S Sriprasad N Shrotri R Tiptaft 2001 Have stent-related symptoms anything to do with placement technique? J Endourol 15 741 745 10.1089/08927790152596352 (Pubitemid 32954386)